The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, heralded the latest research from a group of leading experts based in the United Kingdom. The study, published in the American Journal of Therapeutics, used the highest scientific standards to evaluate the efficacy of ivermectin and found that “large reductions in COVID-19 deaths are possible with the use of ivermectin.”
In conducting their extensive review of the evidence on ivermectin, the researchers applied the Cochrane Library standard for a systematic review. This standard is considered the highest quality medication review protocol in the world. Researchers included Drs. Andrew Bryant, Tess Lawrie, Edmund Fordham, Therese Dowswell, Scott Mitchell, Sarah Hill and Today Tham.
“As medical authorities continue to fail in developing an early treatment option for COVID-19, this new research will make history as it provides more than sufficient evidence for the power of ivermectin to prevent hospitalization and death from COVID-19,” said Dr. Pierre Kory, president and chief medical officer of the FLCCC. “COVID-19 is now proven once again as a treatable disease outside the hospital. Continuing to ignore this evidence the way WHO, NIH, and other health institutes have is to ignore science and is prolonging the suffering and death of this pandemic.”
“This research proves what we have seen every day in our offices and hospitals. When ivermectin is used, our patients heal from this terrible disease,” said Paul E. Marik, M.D., FCCM, FCCP, founding member of the FLCCC and Chief, Pulmonary and Critical Care Medicine at Eastern Virginia Medical School. “If the governments and the WHO wants to see more evidence, here it is. This is more than enough to show that ivermectin should be the standard of care for COVID-19.”
The paper published in the American Journal of Therapeutics.
